Pattech Fitwell Tube Components Limited IPO Message Board (Page 1)

🙏🏻

Arjun bhai Isne to kamai de di bhai.

Cant understand the market behavior. Anyways good luck for all those who invested.

Pattech Fitwell Tube Components Ltd NSE SME IPO.
Code:-15143
Symbol:-PATTECH
Group:-ST
ISIN:-INE0NZW01014
Issue Price:-50/-
Market Lot:-3000 Shares
Face Value:-10/-
Listing At:-NSE SME

Finally 1.5/- buyer

Avoiding this due to stagnant revenue and high valuation.

Skipped this one. But am surprised by the subscription figure.... That it managed to get 2x is an achievement in itself by the managers especially when all the relevant data were going against it.
Won't be surprised if it gets a good listing.

Kuchhh bada hone vala hai

Skipped

Avoided

Fix 1212

But 1212 is still not promising. I am giving it a miss.

It is 2nd Patrons Exim. Will be 1/4 of issue price.
Save your capital.

Not worth, high premium
Skipping

Dear Experts
Should we subscribe to this IPo in HNi category. What's the expected GMP or expected listing price?

I am not subscribing. Neither fundamentals nor subscription figures are encouraging.

Didn't find anything encouraging or X factor. Avoiding it.

Ok. Sir. Avoid.

Itna sannatta kyo hai bhai.

This is again a case of corporatization of a firm for IPO due to which financials, past performance is not clearly evident. There are too many negative factors:
1. Fedex (LM) performance of Moxsh
2. ROE/ ROCE is meagre 2-3% as per RHP
3. GMP is running negative
4. Subscriptions are poor uptil now
5. High Debt - 17 cr, DE Ratio 3.26
6. Industry is Asset Heavy with low PE multiple

As of now, would like to give it a miss.

Dear sachit to phir isko bhi moxsh mil jayega

God is Great sir,
Separately Moxsh is at 20% UC today.

RHP Readings
Appears to be a commoditized business with RM cost more than 90% of sales, showing little value addition. 2
Excluding build up in stock in 21-22, the 22- 23 numbers appear comparable to 21-22.
Company has done a decent job on cash flow with cash flow from operations before tax being higher than PBT for 20-21, 21-22 and 22-23
With only 9 employees from top mgmt. to workers, it is a lean operation.
Page 140 of prospectus, Bharat Limbani and Jaysukh Limbani share common residence address however as per section 2(77) of the Companies Act, 2013, they are not related to each other. Never seen unrelated directors sharing common residence !!
Page 142 of prospectus, MD and WTD combined get monthly salary of Rs 6.5 lacs which is Rs 72 lacs per annum which would be 40% of 21-22 profits.
Page 181 of prospectus, company has loan @ 15% from Bajaj Finserv and IDFC First Bank. Although amount is small, why would a cash flow +ve company have such expensive borrowing
Majority of debt is < 6 months ageing which is +ve

विषय से हटके कंपस ऐक्टिव 545 पे मेरे पास 1000 k होल्ड कीया हुआ हे ऐवरज करे या नही अग्रीम मे धन्यवाद

Out of topic_Sudarshan pharma allotted at Rs.73 .CMP 65.70(Today up 12.35%).sell or wait for sometime.please advice

should to sell on cost to cost

Numbers Red flag... Varying net profits on the same 20 crore turnover! 7.74 lakhs to 1.16 lakhs loss to 1.44 crores! seems like manipulated accounting numbers for big ipo valuation - Please avoid.

Do not fall prey to NII numbers. Listing gains very unlikely where 10-12 PE IPOs being listed at issue prices recently.

off the topic .

can plz anybody help me out . i have missed to pay second call money of Suzlon right shares , how can i pay now and get my right shares ..??

LM performance is not bad except Moxsh and Lamerite. Will take a call on last day